| Year |
Citation |
Score |
| 2023 |
Morse RM, Brown J, Gage JC, Prieto BA, Jurczuk M, Matos A, Vásquez Vásquez J, Reátegui RR, Meza-Sanchez G, Córdova LAD, Gravitt PE, Tracy JK, Paz-Soldan VA. "Easy women get it": pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program. Bmc Public Health. 23: 2396. PMID 38042779 DOI: 10.1186/s12889-023-17324-w |
0.33 |
|
| 2023 |
Morse RM, Brown J, Gage JC, Prieto BA, Jurczuk M, Matos A, Vásquez JV, Reátegui RR, Meza-Sanchez G, Córdova LAD, Gravitt PE, Tracy JK, Paz-Soldan VA. "Easy women get it": Pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program. Research Square. PMID 37790338 DOI: 10.21203/rs.3.rs-3256535/v1 |
0.331 |
|
| 2022 |
Desai KT, Adepiti CA, Schiffman M, Egemen D, Gage JC, Wentzensen N, de Sanjose S, Burk RD, Ajenifuja KO. Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management. International Journal of Cancer. PMID 35666530 DOI: 10.1002/ijc.34151 |
0.34 |
|
| 2022 |
Demarco M, Egemen D, Hyun N, Chen X, Moscicki AB, Cheung L, Carter-Pokras O, Hammer A, Gage JC, Clarke MA, Castle PE, Befano B, Chen J, Dallal C, He X, et al. Contribution of Etiologic Cofactors to CIN3+ Risk Among Women With Human Papillomavirus-Positive Screening Test Results. Journal of Lower Genital Tract Disease. PMID 35249974 DOI: 10.1097/LGT.0000000000000667 |
0.327 |
|
| 2022 |
Mix J, Saraiya M, Hallowell BD, Befano B, Cheung LC, Unger ER, Gargano JW, Markowitz LE, Castle PE, Raine-Bennett T, Walker J, Zuna R, Schiffman M, Wentzensen N, Gage JC. Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management. Journal of the National Cancer Institute. PMID 35176161 DOI: 10.1093/jnci/djac034 |
0.312 |
|
| 2021 |
Gage JC, Raine-Bennett T, Schiffman M, Clarke MA, Cheung LC, Poitras NE, Varnado NE, Katki HA, Castle PE, Befano B, Chandra M, Rydzak G, Lorey T, Wentzensen N. The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34789470 DOI: 10.1158/1055-9965.EPI-21-0865 |
0.316 |
|
| 2021 |
Raine-Bennett T, Gage JC, Poitras N, Chandra M, Varnado N, Befano B, Schiffman M, Lorey T, Wentzensen N. Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS). Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 145: 105014. PMID 34768232 DOI: 10.1016/j.jcv.2021.105014 |
0.351 |
|
| 2021 |
Torres KL, Rondon HHMF, Martins TR, Martins S, Ribeiro A, Raiol T, Marques CP, Corrêa F, Migowski A, Minuzzi-Souza TTCE, Schiffman M, Rodriguez AC, Gage JC. Moving towards a strategy to accelerate cervical cancer elimination in a high-burden city-Lessons learned from the Amazon city of Manaus, Brazil. Plos One. 16: e0258539. PMID 34662368 DOI: 10.1371/journal.pone.0258539 |
0.326 |
|
| 2020 |
Desai KT, Ajenifuja KO, Banjo A, Adepiti CA, Novetsky A, Sebag C, Einstein MH, Oyinloye T, Litwin TR, Horning M, Olanrewaju FO, Oripelaye MM, Afolabi E, Odujoko OO, Castle PE, ... ... Gage JC, et al. Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage. Infectious Agents and Cancer. 15: 60. PMID 33072178 DOI: 10.1186/s13027-020-00324-5 |
0.309 |
|
| 2020 |
Baena A, Agudelo MC, Lopez C, Ramírez AT, Castañeda KM, Bedoya AM, Riveros M, Posada G, Borrero M, Buitrago CA, Suescun D, Gomez LJ, Ochoa JC, Stoler M, Gage J, et al. Comparison of immediate colposcopy, repeat conventional cytology and hrHPV testing for the clinical management of ASC-US cytology in routine health services of Medellin, Colombia: The ASCUS-COL Trial. International Journal of Cancer. PMID 33006400 DOI: 10.1002/ijc.33318 |
0.325 |
|
| 2020 |
Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, Hammer A, Campos N, Kinney W, Gage JC, Befano B, Perkins RB, He X, Dallal C, Chen J, et al. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. Eclinicalmedicine. 22: 100293. PMID 32510043 DOI: 10.1016/J.Eclinm.2020.100293 |
0.353 |
|
| 2020 |
Pinheiro M, Gage JC, Clifford GM, Demarco M, Cheung LC, Chen Z, Yeager M, Cullen M, Boland JF, Chen X, Raine-Bennett T, Steinberg M, Bass S, Befano B, Xiao Y, et al. Association of HPV35 with cervical carcinogenesis among women of African ancestry: evidence of viral-host interaction with implications for disease intervention. International Journal of Cancer. PMID 32363580 DOI: 10.1002/Ijc.33033 |
0.337 |
|
| 2020 |
Demarco M, Egemen D, Raine-Bennett TR, Cheung LC, Befano B, Poitras NE, Lorey TS, Chen X, Gage JC, Castle PE, Wentzensen N, Perkins RB, Guido RS, Schiffman M. A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines. Journal of Lower Genital Tract Disease. 24: 144-147. PMID 32243309 DOI: 10.1097/Lgt.0000000000000530 |
0.317 |
|
| 2019 |
Campos NG, Alfaro K, Maza M, Sy S, Melendez M, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M, Kim J. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador. Preventive Medicine. 105931. PMID 31765712 DOI: 10.1016/J.Ypmed.2019.105931 |
0.318 |
|
| 2019 |
Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Masch R, Cremer M, Kim JJ. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 30702142 DOI: 10.1002/Ijgo.12773 |
0.336 |
|
| 2018 |
Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Poitras NE, Lorey TS, Katki HA, Wentzensen N, Schiffman M. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results. Journal of the National Cancer Institute. PMID 30576462 DOI: 10.1093/Jnci/Djy192 |
0.308 |
|
| 2018 |
Yu K, Hyun N, Fetterman B, Lorey T, Raine-Bennett TR, Zhang H, Stamps RE, Poitras NE, Wheeler W, Befano B, Gage JC, Castle PE, Wentzensen N, Schiffman M. Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology. Journal of the National Cancer Institute. PMID 29659930 DOI: 10.1093/Jnci/Djy044 |
0.352 |
|
| 2018 |
Demarco M, Carter-Pokras O, Hyun N, Castle PE, He X, Dallal CM, Chen J, Gage JC, Befano B, Fetterman B, Lorey T, Poitras N, Raine-Bennett TR, Wentzensen N, Schiffman M. Validation of an HPV DNA cervical screening test that provides expanded HPV typing. Journal of Clinical Microbiology. PMID 29491018 DOI: 10.1128/Jcm.01910-17 |
0.31 |
|
| 2017 |
Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Zhao FH, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Katki HA, Schiffman M. Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study. Annals of Internal Medicine. PMID 29181509 DOI: 10.7326/M17-1609 |
0.329 |
|
| 2017 |
Schiffman M, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Castle PE. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening. Journal of the National Cancer Institute. PMID 29145648 DOI: 10.1093/Jnci/Djx225 |
0.342 |
|
| 2017 |
Liu AH, Walker J, Gage JC, Gold MA, Zuna R, Dunn ST, Schiffman M, Wentzensen N. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology. Obstetrics and Gynecology. PMID 29112672 DOI: 10.1097/Aog.0000000000002330 |
0.306 |
|
| 2017 |
Cuzick J, Myers O, Lee JH, Shi Y, Gage JC, Hunt WC, Robertson M, Wheeler CM. Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing. Jama Oncology. PMID 28655061 DOI: 10.1001/Jamaoncol.2017.1040 |
0.305 |
|
| 2017 |
Castle PE, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Schiffman M. Why does cervical cancer occur in a state-of-the-art screening program? Gynecologic Oncology. PMID 28606721 DOI: 10.1016/J.Ygyno.2017.06.003 |
0.306 |
|
| 2017 |
Fokom Domgue J, Schiffman M, Wentzensen NH, Gage JC, Castle PE, Raine-Bennett TR, Fetterman B, Lorey T, Poitras NE, Befano B, Xie Y, Miachon LS, Dean M. Assessment of a new lower-cost real-time PCR detection assay for high-risk HPV: Useful for cervical screening in limited resource settings? Journal of Clinical Microbiology. PMID 28515214 DOI: 10.1128/Jcm.00492-17 |
0.331 |
|
| 2017 |
Maza M, Alfaro K, Garai J, Velado MM, Gage JC, Castle PE, Felix J, Luciani S, Campos N, Kim J, Masch R, Cremer M. Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country. Gynecologic Oncology Reports. 20: 58-61. PMID 28337474 DOI: 10.1016/J.Gore.2017.02.011 |
0.315 |
|
| 2017 |
Maza M, Gage JC. Considerations for HPV primary screening in lower-middle income countries. Preventive Medicine. 98: 39-41. PMID 28279262 DOI: 10.1016/j.ypmed.2016.12.029 |
0.325 |
|
| 2016 |
Silver MI, Schiffman M, Fetterman B, Poitras NE, Gage JC, Wentzensen N, Lorey T, Kinney WK, Castle PE. The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen. Cancer. PMID 27657992 DOI: 10.1002/Cncr.30277 |
0.337 |
|
| 2016 |
Schiffman M, Hyun N, Raine-Bennett TR, Katki H, Fetterman B, Gage JC, Cheung LC, Befano B, Poitras N, Lorey T, Castle PE, Wentzensen NH. A Cohort Study of Cervical Screening Using Partial HPV Typing and Cytology Triage. International Journal of Cancer. PMID 27509172 DOI: 10.1002/Ijc.30375 |
0.338 |
|
| 2016 |
Cremer ML, Maza M, Alfaro KM, Kim JJ, Ditzian LR, Villalta S, Alonzo TA, Felix JC, Castle PE, Gage JC. Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador. Journal of Lower Genital Tract Disease. PMID 26890683 DOI: 10.1097/Lgt.0000000000000188 |
0.322 |
|
| 2016 |
Zhao FH, Hu SY, Zhang Q, Zhang X, Pan QJ, Zhang WH, Gage JC, Wentzensen N, Castle PE, Qiao YL, Katki HA, Schiffman M. Risk assessment to guide cervical screening strategies in a large chinese population. International Journal of Cancer. Journal International Du Cancer. PMID 26800481 DOI: 10.1002/Ijc.30012 |
0.339 |
|
| 2015 |
Santesso N, Mustafa RA, Schünemann HJ, Arbyn M, Blumenthal PD, Cain J, Chirenje M, Denny L, De Vuyst H, Eckert LO, Forhan SE, Franco EL, Gage JC, Garcia F, Herrero R, et al. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 26868062 DOI: 10.1016/J.Ijgo.2015.07.038 |
0.308 |
|
| 2015 |
Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM, Group Author NM. Risk Stratification using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-wide Surveillance Program. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26518316 DOI: 10.1158/1055-9965.Epi-15-0669 |
0.337 |
|
| 2015 |
Alfaro KM, Gage JC, Rosenbaum AJ, Ditzian LR, Maza M, Scarinci IC, Miranda E, Villalta S, Felix JC, Castle PE, Cremer ML. Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program. Bmc Public Health. 15: 1058. PMID 26474762 DOI: 10.1186/s12889-015-2360-7 |
0.302 |
|
| 2015 |
Schiffman M, Vaughan LM, Raine-Bennett TR, Castle PE, Katki HA, Gage JC, Fetterman B, Befano B, Wentzensen N. A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results. Gynecologic Oncology. 138: 573-8. PMID 26148763 DOI: 10.1016/J.Ygyno.2015.06.040 |
0.341 |
|
| 2015 |
Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE. The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1304-10. PMID 26088703 DOI: 10.1158/1055-9965.Epi-14-1353 |
0.341 |
|
| 2015 |
Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Cremer ML, Kim JJ. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador. International Journal of Cancer. Journal International Du Cancer. 137: 893-902. PMID 25639903 DOI: 10.1002/Ijc.29438 |
0.339 |
|
| 2015 |
Gage JC, Katki HA, Schiffman M, Fetterman B, Poitras NE, Lorey T, Cheung LC, Castle PE, Kinney WK. Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection. International Journal of Cancer. 136: 1665-71. PMID 25136967 DOI: 10.1002/Ijc.29143 |
0.321 |
|
| 2015 |
Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE. The role of human papillomavirus genotyping in cervical cancer screening: A large-scale evaluation of the cobas HPV test Cancer Epidemiology Biomarkers and Prevention. 24: 1304-1310. DOI: 10.1158/1055-9965.EPI-14-1353 |
0.323 |
|
| 2014 |
Gage JC, Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Behrens C, Sharma A, Zhao FH, Cuzick J, Yang ZH, Kinney WK. The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management. Cancer Cytopathology. 122: 842-50. PMID 25045058 DOI: 10.1002/Cncy.21463 |
0.328 |
|
| 2014 |
Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, Poitras NE, Lorey T, Cheung LC, Kinney WK. Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. Journal of the National Cancer Institute. 106. PMID 25038467 DOI: 10.1093/Jnci/Dju153 |
0.342 |
|
| 2014 |
Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Sahasrabuddhe VV, Chen J, Lorey TS, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Castle PE. Analytic and clinical performance of cobas HPV testing in anal specimens from HIV-positive men who have sex with men. Journal of Clinical Microbiology. 52: 2892-7. PMID 24899025 DOI: 10.1128/JCM.03517-13 |
0.329 |
|
| 2014 |
Rosenbaum AJ, Gage JC, Alfaro KM, Ditzian LR, Maza M, Scarinci IC, Felix JC, Castle PE, Villalta S, Miranda E, Cremer ML. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 126: 156-60. PMID 24880188 DOI: 10.1016/j.ijgo.2014.02.026 |
0.313 |
|
| 2013 |
Gage JC, Schiffman M, Solomon D, Wheeler CM, Gravitt PE, Castle PE, Wentzensen N. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1095-101. PMID 23603204 DOI: 10.1158/1055-9965.Epi-12-1455 |
0.333 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. Journal of Lower Genital Tract Disease. 17: S78-84. PMID 23519309 DOI: 10.1097/Lgt.0B013E31828543C5 |
0.307 |
|
| 2013 |
Katki HA, Gage JC, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Kinney WK. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less. Journal of Lower Genital Tract Disease. 17: S69-77. PMID 23519308 DOI: 10.1097/Lgt.0B013E31828543B1 |
0.345 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive. Journal of Lower Genital Tract Disease. 17: S56-63. PMID 23519306 DOI: 10.1097/Lgt.0B013E318285437B |
0.343 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results. Journal of Lower Genital Tract Disease. 17: S50-5. PMID 23519305 DOI: 10.1097/Lgt.0B013E3182854282 |
0.346 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results. Journal of Lower Genital Tract Disease. 17: S43-9. PMID 23519304 DOI: 10.1097/Lgt.0B013E3182854269 |
0.334 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results. Journal of Lower Genital Tract Disease. 17: S36-42. PMID 23519303 DOI: 10.1097/Lgt.0B013E3182854253 |
0.353 |
|
| 2013 |
Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. Journal of Lower Genital Tract Disease. 17: S28-35. PMID 23519302 DOI: 10.1097/Lgt.0B013E318285423C |
0.338 |
|
| 2013 |
Castle PE, Gage JC, Partridge EE, Rausa A, Gravitt PE, Scarinci IC. Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta. Bmc Infectious Diseases. 13: 5. PMID 23289357 DOI: 10.1186/1471-2334-13-5 |
0.306 |
|
| 2013 |
Darragh TM, Tokugawa D, Castle PE, Follansbee S, Borgonovo S, LaMere BJ, Schwartz L, Gage JC, Fetterman B, Lorey T, Wentzensen N. Interrater agreement of anal cytology. Cancer Cytopathology. 121: 72-8. PMID 22811048 DOI: 10.1002/cncy.21218 |
0.329 |
|
| 2012 |
Castle PE, Glass AG, Rush BB, Scott DR, Wentzensen N, Gage JC, Buckland J, Rydzak G, Lorincz AT, Wacholder S. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3044-50. PMID 22851570 DOI: 10.1200/JCO.2011.38.8389 |
0.305 |
|
| 2012 |
Gage JC, Sadorra M, LaMere BJ, Kail R, Aldrich C, Kinney W, Fetterman B, Lorey T, Schiffman M, Castle PE. Comparison of the cobas human papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests Journal of Clinical Microbiology. 50: 61-65. PMID 22075592 DOI: 10.1128/Jcm.05989-11 |
0.326 |
|
| 2012 |
Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, Hutchinson M, Wacholder S, Harford J, Soliman AS, Burk RD, Schiffman M. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. International Journal of Cancer. Journal International Du Cancer. 130: 2111-7. PMID 21630264 DOI: 10.1002/Ijc.26211 |
0.341 |
|
| 2011 |
Castle PE, Gage JC, Wheeler CM, Schiffman M. The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy. Obstetrics and Gynecology. 118: 1222-9. PMID 22105250 DOI: 10.1097/Aog.0B013E318237Caf4 |
0.329 |
|
| 2011 |
Gage JC, Partridge EE, Rausa A, Gravitt PE, Wacholder S, Schiffman M, Scarinci I, Castle PE. Comparative performance of human papillomavirus DNA testing using novel sample collection methods. Journal of Clinical Microbiology. 49: 4185-9. PMID 21998422 DOI: 10.1128/Jcm.01254-11 |
0.305 |
|
| 2011 |
Clarke MA, Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Wacholder S, Burk RD, Schiffman M. A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria. Infectious Agents and Cancer. 6: 12. PMID 21801395 DOI: 10.1186/1750-9378-6-12 |
0.31 |
|
| 2011 |
Yang HP, Walmer DK, Merisier D, Gage JC, Bell L, Rangwala S, Shrestha N, Kobayashi L, Eder PS, Castle PE. A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test. Journal of Virological Methods. 176: 112-4. PMID 21640138 DOI: 10.1016/j.jviromet.2011.05.024 |
0.311 |
|
| 2011 |
Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. Journal of the National Cancer Institute. 103: 368-83. PMID 21282563 DOI: 10.1093/Jnci/Djq562 |
0.355 |
|
| 2010 |
Gage JC, Schiffman M, Solomon D, Wheeler CM, Castle PE. Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1668-74. PMID 20615884 DOI: 10.1158/1055-9965.Epi-09-1286 |
0.339 |
|
| 2009 |
Gage JC, Rodriguez AC, Schiffman M, Garcia FM, Long RL, Budihas SR, Herrero R, Burk RD, Jeronimo J. Treatability by cryotherapy in a screen-and-treat strategy. Journal of Lower Genital Tract Disease. 13: 174-81. PMID 19550216 DOI: 10.1097/Lgt.0B013E3181909F30 |
0.304 |
|
| 2009 |
Gage JC, Rodriguez AC, Schiffman M, Adadevoh S, Larraondo MJ, Chumworathayi B, Lejarza SV, Araya LV, Garcia F, Budihas SR, Long R, Katki HA, Herrero R, Burk RD, Jeronimo J. An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 19: 728-33. PMID 19509579 DOI: 10.1111/Igc.0B013E3181A48B99 |
0.304 |
|
| 2009 |
Safaeian M, Schiffman M, Gage J, Solomon D, Wheeler CM, Castle PE. Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Research. 69: 3262-6. PMID 19351830 DOI: 10.1158/0008-5472.Can-08-4192 |
0.328 |
|
| Show low-probability matches. |